• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

DirkEaston's Profile

Avatar:

Membership:

Premium

Person Marks:

0

Total Posts:

691

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

04/21/2017 8:27:23 AM

Personal info

Recent Articles

• Vanguard Food LP Transforms North American Produce Landscape
• Instil Bio Welcomes Dr. Jamie Freedman as Chief Medical Officer
• LYR-210 Shows Promising Results in Chronic Rhinosinusitis Study
• Village Farms Transitions to Cannabis with Fresh Produce Sale
• Jade Biosciences Reveals Promising New Insights on JADE101
• Kymera Therapeutics Reports Breakthrough Results for KT-621 Launch
• CW Petroleum Corp Sees Solid Sales Growth in 2025 Update
• Nurix Therapeutics and Sanofi Expand Collaboration on STAT6 Program
• Relay Therapeutics Unveils Promising RLY-2608 Data at ASCO 2025
• BioCryst Pharmaceuticals to Share Breakthrough Data at EAACI
• Zscaler Excels in CyberRatings.org Security Performance Test
• uniQure Advances Path for AMT-130 in Huntington’s Disease Care
• West Fraser Timber Enhances Liquidity with Credit Facility Renewal
• Regeneron Enhances Obesity Solutions with New Licensing Deal
• IsoEnergy Launches Strategic Equity Program to Boost Growth
• Novonesis Finalizes dsm-firmenich Feed Enzyme Alliance Deal
• Cyngn's Dealer Portal Launch: Driving Growth and Efficiency
• dsm-firmenich Achieves Major Sale of Feed Enzymes Alliance Stake
• Anixa Biosciences Reaches Milestone in Breast Cancer Vaccine Trial
• Hyundai's MyHyundai App Tops J.D. Power EV Rankings Again
• Guidelines for Homeowners to Fortify Against Hurricanes
• Alkermes Showcases Vital Developments in Psychiatry Innovation
• KORE Welcomes Anthony Bellomo as New CFO Driving Growth
• Explore Altair's Innovative Solutions at the Paris Air Show
• Assured Data Protection Expands Services with New Offerings
• Trevi Therapeutics Shares Promising Outcomes from Clinical Trial Results
• Grady Health System Unveils New Medical Helicopter for Emergencies
• Alithya Expands Capabilities Through Strategic eVerge Acquisition
• Grünenthal Strengthens Presence in Latin America with Cialis Acquisition
• Embrace the Great Outdoors: Enhancing Life's Journey
• Cambridge Global Advisors Welcomes New Leaders to Enhance Strategy
• REGENXBIO Announces Webcast on Interim Data from RGX-202
• Exciting Summer Offer: Enjoy $6.99 Pizzas at Domino's
• Exciting Offers for Fans Ahead of FIFA Club World Cup
• Exploring Chengdu: A Journey Through China’s Cultural Heart
• Innovative Joint Care Launch: TYLENOL Takes a New Step Forward
• Timothy A. Graham Appointed as Timken's New President
• BioNTech and Bristol Myers Squibb Team Up for Cancer Advancements
• Vera Therapeutics Reports Significant Proteinuria Reduction in IgAN Trial
• Frontera Energy Revises Tender Offer and Increases Amount
• Eshbal Functional Food Inc. Reports Impressive Q1 Results
• Uranium Energy Corp's Growth Accelerates With Milestones Achieved
• KAHR Bio's DSP107 Demonstrates Promise in Colorectal Cancer Treatment
• Southwest Airlines and China Airlines Forge Special Bond
• AZZ Inc. Engages in Wolfe Research's Annual Materials Conference
• Immunic's Upcoming June Conferences for Innovation and Research
• Innovative Navigation Solution for UAVs in GNSS-Challenged Areas
• Atlantic Nickel's Innovative Role in the Future of North America's Minerals
• Liquidia's New Inhalation Powder YUTREPIA Sets Market Debut
• Piedmont REIT Boosts Leasing Expectations Amid Strong Market Demand